Global and China Recombinant Protein Drug R&D Market Size, Status and Forecast 2024-2031

Report ID: 1024649 | Published Date: Sep 2024 | No. of Page: 115 | Base Year: 2023 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Recombinant Protein Drug R&D Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Peptide Hormones
        1.2.3 Hematopoietic Factor
        1.2.4 Cytokines
        1.2.5 Plasma Protein Factor
        1.2.6 Recombinase
        1.2.7 Fusion Protein
        1.2.8 Other
    1.3 Market by Application
        1.3.1 Global Recombinant Protein Drug R&D Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Diabetes
        1.3.3 Dwarfism
        1.3.4 Hemophilia
        1.3.5 Heart Disease
        1.3.6 Cancer
        1.3.7 Other
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Recombinant Protein Drug R&D Market Perspective (2016-2027)
    2.2 Recombinant Protein Drug R&D Growth Trends by Regions
        2.2.1 Recombinant Protein Drug R&D Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Recombinant Protein Drug R&D Historic Market Share by Regions (2016-2021)
        2.2.3 Recombinant Protein Drug R&D Forecasted Market Size by Regions (2022-2027)
    2.3 Recombinant Protein Drug R&D Industry Dynamic
        2.3.1 Recombinant Protein Drug R&D Market Trends
        2.3.2 Recombinant Protein Drug R&D Market Drivers
        2.3.3 Recombinant Protein Drug R&D Market Challenges
        2.3.4 Recombinant Protein Drug R&D Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Recombinant Protein Drug R&D Players by Revenue
        3.1.1 Global Top Recombinant Protein Drug R&D Players by Revenue (2016-2021)
        3.1.2 Global Recombinant Protein Drug R&D Revenue Market Share by Players (2016-2021)
    3.2 Global Recombinant Protein Drug R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Recombinant Protein Drug R&D Revenue
    3.4 Global Recombinant Protein Drug R&D Market Concentration Ratio
        3.4.1 Global Recombinant Protein Drug R&D Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Recombinant Protein Drug R&D Revenue in 2020
    3.5 Recombinant Protein Drug R&D Key Players Head office and Area Served
    3.6 Key Players Recombinant Protein Drug R&D Product Solution and Service
    3.7 Date of Enter into Recombinant Protein Drug R&D Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Recombinant Protein Drug R&D Breakdown Data by Type
    4.1 Global Recombinant Protein Drug R&D Historic Market Size by Type (2016-2021)
    4.2 Global Recombinant Protein Drug R&D Forecasted Market Size by Type (2022-2027)

5 Recombinant Protein Drug R&D Breakdown Data by Application
    5.1 Global Recombinant Protein Drug R&D Historic Market Size by Application (2016-2021)
    5.2 Global Recombinant Protein Drug R&D Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Recombinant Protein Drug R&D Market Size (2016-2027)
    6.2 North America Recombinant Protein Drug R&D Market Size by Type
        6.2.1 North America Recombinant Protein Drug R&D Market Size by Type (2016-2021)
        6.2.2 North America Recombinant Protein Drug R&D Market Size by Type (2022-2027)
        6.2.3 North America Recombinant Protein Drug R&D Market Size by Type (2016-2027)
    6.3 North America Recombinant Protein Drug R&D Market Size by Application
        6.3.1 North America Recombinant Protein Drug R&D Market Size by Application (2016-2021)
        6.3.2 North America Recombinant Protein Drug R&D Market Size by Application (2022-2027)
        6.3.3 North America Recombinant Protein Drug R&D Market Size by Application (2016-2027)
    6.4 North America Recombinant Protein Drug R&D Market Size by Country
        6.4.1 North America Recombinant Protein Drug R&D Market Size by Country (2016-2021)
        6.4.2 North America Recombinant Protein Drug R&D Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Recombinant Protein Drug R&D Market Size (2016-2027)
    7.2 Europe Recombinant Protein Drug R&D Market Size by Type
        7.2.1 Europe Recombinant Protein Drug R&D Market Size by Type (2016-2021)
        7.2.2 Europe Recombinant Protein Drug R&D Market Size by Type (2022-2027)
        7.2.3 Europe Recombinant Protein Drug R&D Market Size by Type (2016-2027)
    7.3 Europe Recombinant Protein Drug R&D Market Size by Application
        7.3.1 Europe Recombinant Protein Drug R&D Market Size by Application (2016-2021)
        7.3.2 Europe Recombinant Protein Drug R&D Market Size by Application (2022-2027)
        7.3.3 Europe Recombinant Protein Drug R&D Market Size by Application (2016-2027)
    7.4 Europe Recombinant Protein Drug R&D Market Size by Country
        7.4.1 Europe Recombinant Protein Drug R&D Market Size by Country (2016-2021)
        7.4.2 Europe Recombinant Protein Drug R&D Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Recombinant Protein Drug R&D Market Size (2016-2027)
    8.2 Asia-Pacific Recombinant Protein Drug R&D Market Size by Type
        8.2.1 Asia-Pacific Recombinant Protein Drug R&D Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Recombinant Protein Drug R&D Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Recombinant Protein Drug R&D Market Size by Type (2016-2027)
    8.3 Asia-Pacific Recombinant Protein Drug R&D Market Size by Application
        8.3.1 Asia-Pacific Recombinant Protein Drug R&D Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Recombinant Protein Drug R&D Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Recombinant Protein Drug R&D Market Size by Application (2016-2027)
    8.4 Asia-Pacific Recombinant Protein Drug R&D Market Size by Region
        8.4.1 Asia-Pacific Recombinant Protein Drug R&D Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Recombinant Protein Drug R&D Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Recombinant Protein Drug R&D Market Size (2016-2027)
    9.2 Latin America Recombinant Protein Drug R&D Market Size by Type
        9.2.1 Latin America Recombinant Protein Drug R&D Market Size by Type (2016-2021)
        9.2.2 Latin America Recombinant Protein Drug R&D Market Size by Type (2022-2027)
        9.2.3 Latin America Recombinant Protein Drug R&D Market Size by Type (2016-2027)
    9.3 Latin America Recombinant Protein Drug R&D Market Size by Application
        9.3.1 Latin America Recombinant Protein Drug R&D Market Size by Application (2016-2021)
        9.3.2 Latin America Recombinant Protein Drug R&D Market Size by Application (2022-2027)
        9.3.3 Latin America Recombinant Protein Drug R&D Market Size by Application (2016-2027)
    9.4 Latin America Recombinant Protein Drug R&D Market Size by Country
        9.4.1 Latin America Recombinant Protein Drug R&D Market Size by Country (2016-2021)
        9.4.2 Latin America Recombinant Protein Drug R&D Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Recombinant Protein Drug R&D Market Size (2016-2027)
    10.2 Middle East & Africa Recombinant Protein Drug R&D Market Size by Type
        10.2.1 Middle East & Africa Recombinant Protein Drug R&D Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Recombinant Protein Drug R&D Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Recombinant Protein Drug R&D Market Size by Type (2016-2027)
    10.3 Middle East & Africa Recombinant Protein Drug R&D Market Size by Application
        10.3.1 Middle East & Africa Recombinant Protein Drug R&D Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Recombinant Protein Drug R&D Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Recombinant Protein Drug R&D Market Size by Application (2016-2027)
    10.4 Middle East & Africa Recombinant Protein Drug R&D Market Size by Country
        10.4.1 Middle East & Africa Recombinant Protein Drug R&D Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Recombinant Protein Drug R&D Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Eli Lilly
        11.1.1 Eli Lilly Company Details
        11.1.2 Eli Lilly Business Overview
        11.1.3 Eli Lilly Recombinant Protein Drug R&D Introduction
        11.1.4 Eli Lilly Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.1.5 Eli Lilly Recent Development
    11.2 Novo Nordisk
        11.2.1 Novo Nordisk Company Details
        11.2.2 Novo Nordisk Business Overview
        11.2.3 Novo Nordisk Recombinant Protein Drug R&D Introduction
        11.2.4 Novo Nordisk Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.2.5 Novo Nordisk Recent Development
    11.3 Amgen
        11.3.1 Amgen Company Details
        11.3.2 Amgen Business Overview
        11.3.3 Amgen Recombinant Protein Drug R&D Introduction
        11.3.4 Amgen Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.3.5 Amgen Recent Development
    11.4 Merck
        11.4.1 Merck Company Details
        11.4.2 Merck Business Overview
        11.4.3 Merck Recombinant Protein Drug R&D Introduction
        11.4.4 Merck Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.4.5 Merck Recent Development
    11.5 Sanofi
        11.5.1 Sanofi Company Details
        11.5.2 Sanofi Business Overview
        11.5.3 Sanofi Recombinant Protein Drug R&D Introduction
        11.5.4 Sanofi Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.5.5 Sanofi Recent Development
    11.6 Pfizer
        11.6.1 Pfizer Company Details
        11.6.2 Pfizer Business Overview
        11.6.3 Pfizer Recombinant Protein Drug R&D Introduction
        11.6.4 Pfizer Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.6.5 Pfizer Recent Development
    11.7 Roche
        11.7.1 Roche Company Details
        11.7.2 Roche Business Overview
        11.7.3 Roche Recombinant Protein Drug R&D Introduction
        11.7.4 Roche Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.7.5 Roche Recent Development
    11.8 Gensci
        11.8.1 Gensci Company Details
        11.8.2 Gensci Business Overview
        11.8.3 Gensci Recombinant Protein Drug R&D Introduction
        11.8.4 Gensci Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.8.5 Gensci Recent Development
    11.9 Ankebio
        11.9.1 Ankebio Company Details
        11.9.2 Ankebio Business Overview
        11.9.3 Ankebio Recombinant Protein Drug R&D Introduction
        11.9.4 Ankebio Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.9.5 Ankebio Recent Development
    11.10 United Cell
        11.10.1 United Cell Company Details
        11.10.2 United Cell Business Overview
        11.10.3 United Cell Recombinant Protein Drug R&D Introduction
        11.10.4 United Cell Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.10.5 United Cell Recent Development
    11.11 Sinobioway Hygene
        11.11.1 Sinobioway Hygene Company Details
        11.11.2 Sinobioway Hygene Business Overview
        11.11.3 Sinobioway Hygene Recombinant Protein Drug R&D Introduction
        11.11.4 Sinobioway Hygene Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.11.5 Sinobioway Hygene Recent Development
    11.12 Kexing
        11.12.1 Kexing Company Details
        11.12.2 Kexing Business Overview
        11.12.3 Kexing Recombinant Protein Drug R&D Introduction
        11.12.4 Kexing Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.12.5 Kexing Recent Development
    11.13 Dongbao
        11.13.1 Dongbao Company Details
        11.13.2 Dongbao Business Overview
        11.13.3 Dongbao Recombinant Protein Drug R&D Introduction
        11.13.4 Dongbao Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.13.5 Dongbao Recent Development
    11.14 3sbio
        11.14.1 3sbio Company Details
        11.14.2 3sbio Business Overview
        11.14.3 3sbio Recombinant Protein Drug R&D Introduction
        11.14.4 3sbio Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.14.5 3sbio Recent Development
    11.15 Gan&Lee
        11.15.1 Gan&Lee Company Details
        11.15.2 Gan&Lee Business Overview
        11.15.3 Gan&Lee Recombinant Protein Drug R&D Introduction
        11.15.4 Gan&Lee Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.15.5 Gan&Lee Recent Development
    11.16 Hengrui
        11.16.1 Hengrui Company Details
        11.16.2 Hengrui Business Overview
        11.16.3 Hengrui Recombinant Protein Drug R&D Introduction
        11.16.4 Hengrui Revenue in Recombinant Protein Drug R&D Business (2016-2021)
        11.16.5 Hengrui Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Recombinant Protein Drug R&D Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Peptide Hormones
    Table 3. Key Players of Hematopoietic Factor
    Table 4. Key Players of Cytokines
    Table 5. Key Players of Plasma Protein Factor
    Table 6. Key Players of Recombinase
    Table 7. Key Players of Fusion Protein
    Table 8. Key Players of Other
    Table 9. Global Recombinant Protein Drug R&D Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 10. Global Recombinant Protein Drug R&D Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 11. Global Recombinant Protein Drug R&D Market Size by Regions (2016-2021) & (US$ Million)
    Table 12. Global Recombinant Protein Drug R&D Market Share by Regions (2016-2021)
    Table 13. Global Recombinant Protein Drug R&D Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 14. Global Recombinant Protein Drug R&D Market Share by Regions (2022-2027)
    Table 15. Recombinant Protein Drug R&D Market Trends
    Table 16. Recombinant Protein Drug R&D Market Drivers
    Table 17. Recombinant Protein Drug R&D Market Challenges
    Table 18. Recombinant Protein Drug R&D Market Restraints
    Table 19. Global Recombinant Protein Drug R&D Revenue by Players (2016-2021) & (US$ Million)
    Table 20. Global Recombinant Protein Drug R&D Market Share by Players (2016-2021)
    Table 21. Global Top Recombinant Protein Drug R&D Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Protein Drug R&D as of 2020)
    Table 22. Ranking of Global Top Recombinant Protein Drug R&D Companies by Revenue (US$ Million) in 2020
    Table 23. Global 5 Largest Players Market Share by Recombinant Protein Drug R&D Revenue (CR5 and HHI) & (2016-2021)
    Table 24. Key Players Headquarters and Area Served
    Table 25. Key Players Recombinant Protein Drug R&D Product Solution and Service
    Table 26. Date of Enter into Recombinant Protein Drug R&D Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Recombinant Protein Drug R&D Market Size by Type (2016-2021) (US$ Million)
    Table 29. Global Recombinant Protein Drug R&D Revenue Market Share by Type (2016-2021)
    Table 30. Global Recombinant Protein Drug R&D Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 31. Global Recombinant Protein Drug R&D Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 32. Global Recombinant Protein Drug R&D Market Size Share by Application (2016-2021) & (US$ Million)
    Table 33. Global Recombinant Protein Drug R&D Revenue Market Share by Application (2016-2021)
    Table 34. Global Recombinant Protein Drug R&D Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 35. Global Recombinant Protein Drug R&D Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 36. North America Recombinant Protein Drug R&D Market Size by Type (2016-2021) (US$ Million)
    Table 37. North America Recombinant Protein Drug R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 38. North America Recombinant Protein Drug R&D Market Size by Application (2016-2021) (US$ Million)
    Table 39. North America Recombinant Protein Drug R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 40. North America Recombinant Protein Drug R&D Market Size by Country (2016-2021) & (US$ Million) 
    Table 41. North America Recombinant Protein Drug R&D Market Size by Country (2022-2027) & (US$ Million) 
    Table 42. Europe Recombinant Protein Drug R&D Market Size by Type (2016-2021) (US$ Million)
    Table 43. Europe Recombinant Protein Drug R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 44. Europe Recombinant Protein Drug R&D Market Size by Application (2016-2021) (US$ Million)
    Table 45. Europe Recombinant Protein Drug R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 46. Europe Recombinant Protein Drug R&D Market Size by Country (2016-2021) & (US$ Million) 
    Table 47. Europe Recombinant Protein Drug R&D Market Size by Country (2022-2027) & (US$ Million) 
    Table 48. Asia-Pacific Recombinant Protein Drug R&D Market Size by Type (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Recombinant Protein Drug R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Recombinant Protein Drug R&D Market Size by Application (2016-2021) (US$ Million)
    Table 51. Asia-Pacific Recombinant Protein Drug R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 52. Asia-Pacific Recombinant Protein Drug R&D Market Size by Region (2016-2021) & (US$ Million) 
    Table 53. Asia-Pacific Recombinant Protein Drug R&D Market Size by Region (2022-2027) & (US$ Million) 
    Table 54. Latin America Recombinant Protein Drug R&D Market Size by Type (2016-2021) (US$ Million)
    Table 55. Latin America Recombinant Protein Drug R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 56. Latin America Recombinant Protein Drug R&D Market Size by Application (2016-2021) (US$ Million)
    Table 57. Latin America Recombinant Protein Drug R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 58. Latin America Recombinant Protein Drug R&D Market Size by Country (2016-2021) & (US$ Million) 
    Table 59. Latin America Recombinant Protein Drug R&D Market Size by Country (2022-2027) & (US$ Million) 
    Table 60. Middle East & Africa Recombinant Protein Drug R&D Market Size by Type (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Recombinant Protein Drug R&D Market Size by Type (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Recombinant Protein Drug R&D Market Size by Application (2016-2021) (US$ Million)
    Table 63. Middle East & Africa Recombinant Protein Drug R&D Market Size by Application (2022-2027) & (US$ Million)
    Table 64. Middle East & Africa Recombinant Protein Drug R&D Market Size by Country (2016-2021) & (US$ Million) 
    Table 65. Middle East & Africa Recombinant Protein Drug R&D Market Size by Country (2022-2027) & (US$ Million) 
    Table 66. Eli Lilly Company Details
    Table 67. Eli Lilly Business Overview
    Table 68. Eli Lilly Recombinant Protein Drug R&D Product
    Table 69. Eli Lilly Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 70. Eli Lilly Recent Development
    Table 71. Novo Nordisk Company Details
    Table 72. Novo Nordisk Business Overview
    Table 73. Novo Nordisk Recombinant Protein Drug R&D Product
    Table 74. Novo Nordisk Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 75. Novo Nordisk Recent Development
    Table 76. Amgen Company Details
    Table 77. Amgen Business Overview
    Table 78. Amgen Recombinant Protein Drug R&D Product
    Table 79. Amgen Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 80. Amgen Recent Development
    Table 81. Merck Company Details
    Table 82. Merck Business Overview
    Table 83. Merck Recombinant Protein Drug R&D Product
    Table 84. Merck Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 85. Merck Recent Development
    Table 86. Sanofi Company Details
    Table 87. Sanofi Business Overview
    Table 88. Sanofi Recombinant Protein Drug R&D Product
    Table 89. Sanofi Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 90. Sanofi Recent Development
    Table 91. Pfizer Company Details
    Table 92. Pfizer Business Overview
    Table 93. Pfizer Recombinant Protein Drug R&D Product
    Table 94. Pfizer Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 95. Pfizer Recent Development
    Table 96. Roche Company Details
    Table 97. Roche Business Overview
    Table 98. Roche Recombinant Protein Drug R&D Product
    Table 99. Roche Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 100. Roche Recent Development
    Table 101. Gensci Company Details
    Table 102. Gensci Business Overview
    Table 103. Gensci Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 104. Gensci Recent Development
    Table 105. Ankebio Company Details
    Table 106. Ankebio Business Overview
    Table 107. Ankebio Recombinant Protein Drug R&D Product
    Table 108. Ankebio Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 109. Ankebio Recent Development
    Table 110. United Cell Company Details
    Table 111. United Cell Business Overview
    Table 112. United Cell Recombinant Protein Drug R&D Product
    Table 113. United Cell Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 114. United Cell Recent Development
    Table 115. Sinobioway Hygene Company Details
    Table 116. Sinobioway Hygene Business Overview
    Table 117. Sinobioway Hygene Recombinant Protein Drug R&D Product
    Table 118. Sinobioway Hygene Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 119. Sinobioway Hygene Recent Development
    Table 120. Kexing Company Details
    Table 121. Kexing Business Overview
    Table 122. Kexing Recombinant Protein Drug R&D Product
    Table 123. Kexing Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 124. Kexing Recent Development
    Table 125. Dongbao Company Details
    Table 126. Dongbao Business Overview
    Table 127. Dongbao Recombinant Protein Drug R&D Product
    Table 128. Dongbao Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 129. Dongbao Recent Development
    Table 130. 3sbio Company Details
    Table 131. 3sbio Business Overview
    Table 132. 3sbio Recombinant Protein Drug R&D Product
    Table 133. 3sbio Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 134. 3sbio Recent Development
    Table 135. Gan&Lee Company Details
    Table 136. Gan&Lee Business Overview
    Table 137. Gan&Lee Recombinant Protein Drug R&D Product
    Table 138. Gan&Lee Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 139. Gan&Lee Recent Development
    Table 140. Hengrui Company Details
    Table 141. Hengrui Business Overview
    Table 142. Hengrui Recombinant Protein Drug R&D Product
    Table 143. Hengrui Revenue in Recombinant Protein Drug R&D Business (2016-2021) & (US$ Million)
    Table 144. Hengrui Recent Development
    Table 145. Research Programs/Design for This Report
    Table 146. Key Data Information from Secondary Sources
    Table 147. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Recombinant Protein Drug R&D Market Share by Type: 2020 VS 2027
    Figure 2. Peptide Hormones Features
    Figure 3. Hematopoietic Factor Features
    Figure 4. Cytokines Features
    Figure 5. Plasma Protein Factor Features
    Figure 6. Recombinase Features
    Figure 7. Fusion Protein Features
    Figure 8. Other Features
    Figure 9. Global Recombinant Protein Drug R&D Market Share by Application: 2020 VS 2027
    Figure 10. Diabetes Case Studies
    Figure 11. Dwarfism Case Studies
    Figure 12. Hemophilia Case Studies
    Figure 13. Heart Disease Case Studies
    Figure 14. Cancer Case Studies
    Figure 15. Other Case Studies
    Figure 16. Recombinant Protein Drug R&D Report Years Considered
    Figure 17. Global Recombinant Protein Drug R&D Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 18. Global Recombinant Protein Drug R&D Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 19. Global Recombinant Protein Drug R&D Market Share by Regions: 2020 VS 2027
    Figure 20. Global Recombinant Protein Drug R&D Market Share by Regions (2022-2027)
    Figure 21. Global Recombinant Protein Drug R&D Market Share by Players in 2020
    Figure 22. Global Top Recombinant Protein Drug R&D Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Protein Drug R&D as of 2020
    Figure 23. The Top 10 and 5 Players Market Share by Recombinant Protein Drug R&D Revenue in 2020
    Figure 24. Global Recombinant Protein Drug R&D Revenue Market Share by Type (2016-2021)
    Figure 25. Global Recombinant Protein Drug R&D Revenue Market Share by Type (2022-2027)
    Figure 26. North America Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. North America Recombinant Protein Drug R&D Market Share by Type (2016-2027)
    Figure 28. North America Recombinant Protein Drug R&D Market Share by Application (2016-2027)
    Figure 29. North America Recombinant Protein Drug R&D Market Share by Country (2016-2027)
    Figure 30. United States Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Canada Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Europe Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Europe Recombinant Protein Drug R&D Market Share by Type (2016-2027)
    Figure 34. Europe Recombinant Protein Drug R&D Market Share by Application (2016-2027)
    Figure 35. Europe Recombinant Protein Drug R&D Market Share by Country (2016-2027)
    Figure 36. Germany Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. France Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. U.K. Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Italy Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Russia Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Nordic Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Asia-Pacific Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Asia-Pacific Recombinant Protein Drug R&D Market Share by Type (2016-2027)
    Figure 44. Asia-Pacific Recombinant Protein Drug R&D Market Share by Application (2016-2027)
    Figure 45. Asia-Pacific Recombinant Protein Drug R&D Market Share by Region (2016-2027)
    Figure 46. China Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Japan Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. South Korea Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Southeast Asia Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. India Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Australia Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Latin America Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Latin America Recombinant Protein Drug R&D Market Share by Type (2016-2027)
    Figure 54. Latin America Recombinant Protein Drug R&D Market Share by Application (2016-2027)
    Figure 55. Latin America Recombinant Protein Drug R&D Market Share by Country (2016-2027)
    Figure 56. Mexico Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Brazil Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Middle East & Africa Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Middle East & Africa Recombinant Protein Drug R&D Market Share by Type (2016-2027)
    Figure 60. Middle East & Africa Recombinant Protein Drug R&D Market Share by Application (2016-2027)
    Figure 61. Middle East & Africa Recombinant Protein Drug R&D Market Share by Country (2016-2027)
    Figure 62. Turkey Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. Saudi Arabia Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. UAE Recombinant Protein Drug R&D Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 65. Eli Lilly Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 66. Novo Nordisk Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 67. Amgen Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 68. Merck Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 69. Sanofi Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 70. Pfizer Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 71. Roche Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 72. Gensci Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 73. Ankebio Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 74. United Cell Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 75. Sinobioway Hygene Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 76. Kexing Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 77. Dongbao Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 78. 3sbio Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 79. Gan&Lee Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 80. Hengrui Revenue Growth Rate in Recombinant Protein Drug R&D Business (2016-2021)
    Figure 81. Bottom-up and Top-down Approaches for This Report
    Figure 82. Data Triangulation
    Figure 83. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Eli Lilly
Novo Nordisk
Amgen
Merck
Sanofi
Pfizer
Roche
Gensci
Ankebio
United Cell
Sinobioway Hygene
Kexing
Dongbao
3sbio
Gan&Lee
Hengrui
Frequently Asked Questions
Recombinant Protein Drug R&D report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Recombinant Protein Drug R&D report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Recombinant Protein Drug R&D report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Ending Machine

Ending Machine market is segmented by region (country), players, by Type, and by Application. Pla ... Read More